D3041: Human IgE Myeloma Serum
Our Human IgE Myeloma Serum (Cat# D3041) is a high-IgE biological matrix derived from patients diagnosed with IgE myeloma, a rare immunoglobulin E-producing plasma cell dyscrasia. This unique serum contains >1,000,000 IU/mL of IgE, offering a rich source of immunoglobulin E for use in assay development, allergy-related research, and immunological diagnostics.
Collected and converted from plasma, this material is preservative-free, U.S.-origin, and validated for use in in-vitro research and manufacturing of non-injectable diagnostic products. Each lot undergoes rigorous FDA-approved viral testing and internal quality controls.
Key Features:
High IgE concentration: >1,000,000 IU/mL
Human serum converted from plasma
Preservative-free for maximum assay compatibility
FDA-approved testing: Non-reactive for HIV 1/2, HBsAg, HCV, and RPR
Country of Origin: United States
Storage: -20°C or colder
Available in liter quantities; bulk and custom volumes available upon request
Applications:
Development and calibration of IgE immunoassays
Research in allergic response, asthma, and hypersensitivity reactions
Diagnostic assay validation for immunoglobulin disorders
Reference material for quality control in allergy-related testing platforms
Our Human IgE Myeloma Serum (Cat# D3041) is a high-IgE biological matrix derived from patients diagnosed with IgE myeloma, a rare immunoglobulin E-producing plasma cell dyscrasia. This unique serum contains >1,000,000 IU/mL of IgE, offering a rich source of immunoglobulin E for use in assay development, allergy-related research, and immunological diagnostics.
Collected and converted from plasma, this material is preservative-free, U.S.-origin, and validated for use in in-vitro research and manufacturing of non-injectable diagnostic products. Each lot undergoes rigorous FDA-approved viral testing and internal quality controls.
Key Features:
High IgE concentration: >1,000,000 IU/mL
Human serum converted from plasma
Preservative-free for maximum assay compatibility
FDA-approved testing: Non-reactive for HIV 1/2, HBsAg, HCV, and RPR
Country of Origin: United States
Storage: -20°C or colder
Available in liter quantities; bulk and custom volumes available upon request
Applications:
Development and calibration of IgE immunoassays
Research in allergic response, asthma, and hypersensitivity reactions
Diagnostic assay validation for immunoglobulin disorders
Reference material for quality control in allergy-related testing platforms
Our Human IgE Myeloma Serum (Cat# D3041) is a high-IgE biological matrix derived from patients diagnosed with IgE myeloma, a rare immunoglobulin E-producing plasma cell dyscrasia. This unique serum contains >1,000,000 IU/mL of IgE, offering a rich source of immunoglobulin E for use in assay development, allergy-related research, and immunological diagnostics.
Collected and converted from plasma, this material is preservative-free, U.S.-origin, and validated for use in in-vitro research and manufacturing of non-injectable diagnostic products. Each lot undergoes rigorous FDA-approved viral testing and internal quality controls.
Key Features:
High IgE concentration: >1,000,000 IU/mL
Human serum converted from plasma
Preservative-free for maximum assay compatibility
FDA-approved testing: Non-reactive for HIV 1/2, HBsAg, HCV, and RPR
Country of Origin: United States
Storage: -20°C or colder
Available in liter quantities; bulk and custom volumes available upon request
Applications:
Development and calibration of IgE immunoassays
Research in allergic response, asthma, and hypersensitivity reactions
Diagnostic assay validation for immunoglobulin disorders
Reference material for quality control in allergy-related testing platforms